CompletedNot Applicable

Feasibility of Velocity Loss-Based Volume Prescription During Constant-Load and Chain-Based Smith Machine Back Squats

China26 participantsStarted 2025-10-07

Plain-language summary

The goal of this observational study was to evaluate the feasibility of percentage of velocity loss (%VL)-based approaches for prescribing training volume during constant-load and chain-based Smith machine back squats. The study aimed to answer whether %VL can be expressed as the maximum number of repetitions (%Rep) in constant-load and chain-based Smith machine squats. Twenty-six resistance-trained men performed repetitions-to-failure tests under variable (VRT) and constant resistance training (CRT). The %Rep attained before reaching different levels of effort were compared between VRT and CRT across various loads and sessions. Furthermore, this study evaluated the influence of different factors on the predictive accuracy of the %Rep-%VL relationships. These findings will provide evidence-based evidence in prescribing and monitoring intra-set volume.

Who can participate

Age range

18 Years

Sex

MALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * at least 1 year of resistance training experience, performing back squats at least once per week. * proficiency in the Smith machine back squat executed at maximal intended velocity. * a constant-load 1RM of ≥ 1.5 times their body mass. * no reported musculoskeletal injuries in the past three months. Exclusion Criteria: * Voluntary withdrawal or injury. * Not satisfied with inclusion label.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The %Rep attained before reaching the 10%, 20%, and 30% VL thresholds

Timeframe: April 1st, 2026

The %rep predictive accuracy

Timeframe: April 1st, 2026

Trial details

NCT IDNCT07719010

SponsorSouth China Normal University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-10

View on ClinicalTrials.gov More Loading Configuration trials